|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, United States
2 Dept of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, United States
* To whom correspondence should be addressed. E-mail: hatchma{at}ufl.edu.
To test the hypothesis that colonic Na+ transport is altered in the 5/6 nephrectomized rat model of chronic renal failure (CRF), we measured Na+ fluxes across distal colon from control (CON), CRF, and CRF rats treated with the angiotensin II (ANG II) receptor antagonist losartan (+ LOS). We also evaluated overall fluid and Na+ balance and compared colonic protein and mRNA expression profiles for electroneutral (NHE) and electrogenic Na+ transport (ENaC) in these groups. Consistent with a 60% enhancement in colonic Na+ absorption in CRF, urinary Na+ excretion increased by about 50% while serum Na+ homeostasis was maintained. These CRF-induced changes in Na+ handling were normalized by treatment with LOS. Net Na+ absorption was also stimulated in in vitro tissues from CON rats following acute serosal addition of ANG II (10-7 M) and this increase was blocked by AT1 antagonism, but not by an AT2 antagonist. In CRF, colonic protein and mRNA expression variably increased for apical NHE2, NHE3, and ENaC
-,
-,
-sub-units, while expression of basolateral NHE1 and Na+-K+-ATPase (
-isoform) remained unaltered. Upregulation of the ENaC subunit mRNA was attenuated somewhat by LOS treatment. Previously, we showed that colonic AT1 receptor protein is upregulated 2-fold in CRF and here we find AT1 and AT2 mRNA and AT2 protein abundance is unchanged in CRF. We conclude that Na+ absorption in CRF rat distal colon is increased due to elevated expression of proteins mediating electroneutral and electrogenic uptake and that it is partially mediated by AT1 receptors.
This article has been cited by other articles:
![]() |
H. Suzuki Therapeutic efficacy of renin--angiotensin blockade in patients receiving dialysis Therapeutic Advances in Cardiovascular Disease, October 1, 2009; 3(5): 397 - 405. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |